The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 228K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itoh, N.
Right arrow Articles by Matsuzawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, N.
Right arrow Articles by Matsuzawa, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*UniSTS
Medline Plus Health Information
*Diabetes Type 1
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/8/613/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 4, August 18, 1997 613-618


Brief Definitive Reports

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice

Naoto Itoh*, Akihisa Imagawa{ddagger}, Toshiaki Hanafusa{ddagger}, Masako Waguri{ddagger}, Koji Yamamoto{ddagger}, Hiromi Iwahashi{ddagger}, Makoto Moriwaki{ddagger}, Hiromu Nakajima{ddagger}, Junichiro Miyagawa{ddagger}, Mitsuyoshi Namba{ddagger}, Susumu Makino||, Shigekazu Nagata§, Norio Kono*, and Yuji Matsuzawa{ddagger}

From the * Department of Clinical Laboratory Science, School of Allied Health Sciences, {ddagger} Second Department of Internal Medicine, and § Department of Genetics, Faculty of Medicine, Osaka University, Suita, Osaka 565, Japan; and || Center for Experimental Animals Development, Shionogi & Co., Ltd., Koka, Shiga 520-34, Japan

Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell–mediated autoimmune disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic β cell destruction, we established nonobese diabetic (NOD)-lymphoproliferation (lpr)/lpr mice lacking Fas. Out of three genotypes, female NOD-+/+ and NOD-+/lpr developed spontaneous diabetes by the age of 10 mo with the incidence of 68 and 62%, respectively. In contrast, NOD-lpr/lpr did not develop diabetes or insulitis. To further explore the role of Fas, adoptive transfer experiments were performed. When splenocytes were transferred from diabetic NOD, male NOD-+/+ and NOD-+/lpr developed diabetes with the incidence of 89 and 83%, respectively, whereas NOD-lpr/lpr did not show glycosuria by 12 wk after transfer. Severe mononuclear cell infiltration was revealed in islets of NOD-+/+ and NOD-+/lpr, whereas islet morphology remained intact in NOD-lpr/lpr. These results suggest that Fas-mediated cytotoxicity is required to initiate β cell autoimmunity in NOD mice. Fas–Fas ligand system might be critical for autoimmune β cell destruction leading to IDDM.


Address correspondence to Naoto Itoh, Department of Clinical Laboratory Science, School of Allied Health Sciences, Faculty of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565, Japan. Phone: 81-6-879-2584; FAX: 81-6-879-2499; E-mail: nitoh{at}sahs.med.osaka-u.ac.jp

This study was presented in part at the 57th ADA Meeting, Boston, MA, June 21–24, 1997.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS